Akcea Therapeutics Inc (AKCA) Stock Price, Forecast & Analysis
USA - NASDAQ:AKCA -
AKCA Key Statistics, Chart & Performance
The current stock price of AKCA is 18.17 null. In the past month the price increased by 0.17%. In the past year, price decreased by -8%.
AKCA Latest News, Press Relases and Analysis
About AKCA
Company Profile
Akcea Therapeutics, Inc. is a biopharmaceutical company. It focuses on developing and commercializing drugs to treat patients with cardiometabolic diseases caused by lipid disorders in the United States and internationally. The Company's drug pipeline consists of volanesorsen, AKCEA-APO(a)-LRx, AKCEA-ANGPTL3-LRx and AKCEA-APOCIII-LRx which are in clinical stage. Akcea Therapeutics, Inc. is headquartered in Cambridge, Massachusetts.
Company Info
Akcea Therapeutics Inc
22 BOSTON WHARF RD 9TH FLOOR
BOSTON MA 02210
CEO: Damien McDevitt
Phone: 617-207-0202
Akcea Therapeutics Inc / AKCA FAQ
What does AKCA do?
Akcea Therapeutics, Inc. is a biopharmaceutical company. It focuses on developing and commercializing drugs to treat patients with cardiometabolic diseases caused by lipid disorders in the United States and internationally. The Company's drug pipeline consists of volanesorsen, AKCEA-APO(a)-LRx, AKCEA-ANGPTL3-LRx and AKCEA-APOCIII-LRx which are in clinical stage. Akcea Therapeutics, Inc. is headquartered in Cambridge, Massachusetts.
What is the stock price of Akcea Therapeutics Inc today?
The current stock price of AKCA is 18.17 null. The price increased by 0.17% in the last trading session.
Does AKCA stock pay dividends?
AKCA does not pay a dividend.
How is the ChartMill rating for Akcea Therapeutics Inc?
AKCA has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
Can you provide the market cap for Akcea Therapeutics Inc?
Akcea Therapeutics Inc (AKCA) has a market capitalization of 1.85B null. This makes AKCA a Small Cap stock.
AKCA Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to AKCA. When comparing the yearly performance of all stocks, AKCA is one of the better performing stocks in the market, outperforming 76.92% of all stocks.
AKCA Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to AKCA. AKCA is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average.
AKCA Financial Highlights
Over the last trailing twelve months AKCA reported a non-GAAP Earnings per Share(EPS) of -0.54. The EPS increased by 65.82% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -12.34% | ||
| ROA | -7.86% | ||
| ROE | N/A | ||
| Debt/Equity | 0 |